US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents

Patent application publication

WO2020006018A1 - Substituted naphthyridinone compounds useful as t cell activators - Google Patents

TW202113082A - Antisense oligonucleotides targeting atxn3 - Google Patents

High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression

Ataxin 3 - an overview

US10881730B2 - Immunomodulatory therapeutic MRNA compositions encoding activating oncogene mutation peptides - Google Patents

US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents

US7612114B2 - Selective estrogen receptor modulator - Google Patents

WO2020006018A1 - Substituted naphthyridinone compounds useful as t cell activators - Google Patents

High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression

WO2020006018A1 - Substituted naphthyridinone compounds useful as t cell activators - Google Patents

US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents

US10808039B2 - Monomethylvaline compounds capable of conjugation to ligands - Google Patents

US20200385727A1 - Antisense oligonucleotides targeting atxn3 - Google Patents